Heart Failure With Mildly Reduced Ejection Fraction Registry

Last updated: October 30, 2022
Sponsor: Universitätsmedizin Mannheim
Overall Status: Active - Recruiting

Phase

N/A

Condition

Heart Failure

Chest Pain

Congestive Heart Failure

Treatment

N/A

Clinical Study ID

NCT05603390
2022-818
  • Ages > 18
  • All Genders

Study Summary

Heart failure (HF) affects about 1% of patients younger than 55 years, whereas the prevalence of HF increases > 10% in patients with at least 70 years of age. Despite HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF), the clinical significance of HF with mildly reduced ejection fraction (HFmrEF) has gained more importance within the past years. Those patients are characterized by a left ventricular ejection fraction (LVEF) of 41-49%. However, within the current European guidelines, limited treatment recommendations in this subgroup of HF are yet available as a consequence of the limited number of studies in this field. The "Heart Failure With Mildly Reduced Ejection Fraction Registry" aims to characterize patients with HFmrEF and investigated the prognostic impact of interventional and pharmacological therapies in this subgroup of HF patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with HFmrEF (i.e., LVEF 41-49%)
  • Patients with at least 18 years of age

Exclusion

Exclusion Criteria:

  • Patients younger than 18 years of age

Study Design

Total Participants: 2200
Study Start date:
January 01, 2015
Estimated Completion Date:
January 01, 2023

Connect with a study center

  • University Medical Centre Mannheim

    Mannheim, 68167
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.